The Motley Fool··Motley Fool TranscribingChampions Oncology Posts Record Core Revenue Despite Margin Pressure
Champions Oncology reports 32% YoY core study revenue growth to $16.6M in Q3, but overall revenue falls 3%. Company achieves third consecutive quarter of positive adjusted EBITDA.
CSBRearningsEBITDA